
    
      A repeat-dose open label randomized incomplete block design in pediatric subjects with
      asthma, ages 4-11 years, to compare systemic exposure and pharmacodynamics of fluticasone
      propionate and salmeterol following ADVAIR HFA 45/21mcg(2 inhalations), ADVAIR HFA 45/21mcg(2
      inhalations) with Aerochamber Plus Spacer and ADVAIR DISKUS 100/50 twice daily
    
  